| Author (Corporate) | European Commission: DG Communication |
|---|---|
| Series Title | Press Release |
| Series Details | IP/16/727 (10.03.16) |
| Publication Date | 10/03/2016 |
| Content Type | News |
|
The European Commission approved on 10 March 2016 under the EU Merger Regulation the proposed acquisition of the generics business of Allergan of Ireland, by Teva of Israel, subject to conditions. Both companies were among the top four generic pharmaceutical manufacturers worldwide. |
|
| Source Link | Link to Main Source http://europa.eu/rapid/press-release_IP-16-727_en.htm |
| Subject Categories | Business and Industry, Internal Markets |
| Countries / Regions | Europe |
